U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C4H6N4O
Molecular Weight 126.1168
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 2-Aminoisocytosine

SMILES

NC1=CC(=O)N=C(N)N1

InChI

InChIKey=SWELIMKTDYHAOY-UHFFFAOYSA-N
InChI=1S/C4H6N4O/c5-2-1-3(9)8-4(6)7-2/h1H,(H5,5,6,7,8,9)

HIDE SMILES / InChI

Molecular Formula C4H6N4O
Molecular Weight 126.1168
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

2,4-Diamino-6-hydroxypyrimidine is a selective, specific inhibitor of GTP cyclohydrolase I, a rate-limiting enzyme for the de novo biosynthesis of biopterin. Experiments in rats have shown that 4-Diamino-6-hydroxypyrimidine possesses protective effects against postburn Staphylococcus aureus sepsis.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Target ID: P30793
Gene ID: 2643.0
Gene Symbol: GCH1
Target Organism: Homo sapiens (Human)
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Preventing
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
2,6-Diamino-4-oxo-3,4-dihydropyrim-idin-1-ium chloride dihydrate.
2010-08-11
Design, synthesis and evaluation of 2-amino-4-m-bromoanilino-6-arylmethyl-7H-pyrrolo[2,3-d]pyrimidines as tyrosine kinase inhibitors and antiangiogenic agents.
2010-07-15
Synthesis and biological activity of N(4)-phenylsubstituted-6-(2,4-dichloro phenylmethyl)-7H-pyrrolo[2,3-d]pyrimidine-2,4-diamines as vascular endothelial growth factor receptor-2 inhibitors and antiangiogenic and antitumor agents.
2010-05-15
Tetrahydrobiopterin (BH4), a cofactor for nNOS, restores gastric emptying and nNOS expression in female diabetic rats.
2010-05
Novel riboswitch ligand analogs as selective inhibitors of guanine-related metabolic pathways.
2010-04-22
Synthesis and antitumor activity of a novel series of 6-substituted pyrrolo[2,3-d]pyrimidine thienoyl antifolate inhibitors of purine biosynthesis with selectivity for high affinity folate receptors and the proton-coupled folate transporter over the reduced folate carrier for cellular entry.
2010-02-11
Role of tetrahydrobiopterin in resistance to myocardial ischemia in Brown Norway and Dahl S rats.
2009-11
DFT simulations and vibrational analysis of FT-IR and FT-Raman spectra of 2,4-diamino-6-hydroxypyrimidine.
2009-08-15
Highly diastereoselective domino synthesis of 6-spirosubstituted pyrido[2,3-d]pyrimidine derivatives in water.
2009-06-23
A facile synthetic approach to 7-deazaguanine nucleosides via a Boc protection strategy.
2009-06-04
Metallothionein abrogates GTP cyclohydrolase I inhibition-induced cardiac contractile and morphological defects: role of mitochondrial biogenesis.
2009-06
Acute inhibition of guanosine triphosphate cyclohydrolase 1 uncouples endothelial nitric oxide synthase and elevates blood pressure.
2008-09
Three-day tetrahydrobiopterin therapy increases in vivo hepatic NOS activity and reduces portal pressure in CCl4 cirrhotic rats.
2008-08
Effect of decreased levels of intrinsic tetrahydrobiopterin on endothelial function in anesthetized rats.
2008-05
2,4-Diamino-6-hydroxypyrimidine (DAHP) suppresses cytokine-induced VCAM-1 expression on the cell surface of human umbilical vein endothelial cells in a BH(4)-independent manner.
2007-11-05
Regulation of tetrahydrobiopterin biosynthesis by shear stress.
2007-10-12
Alu recombination-mediated structural deletions in the chimpanzee genome.
2007-10
An efficient route for the synthesis of a new class of pyrido[2,3-d]pyrimidine derivatives.
2007-05-07
C-Reactive protein-induced endothelial microparticle generation in HUVECs is related to BH4-dependent NO formation.
2007
Estrogen therapy replenishes vascular tetrahydrobiopterin and reduces oxidative stress in ovariectomized rats.
2006-04-29
Folic acid reverses endothelial dysfunction induced by inhibition of tetrahydrobiopterin biosynthesis.
2006-01-20
Neural tube closure depends on nitric oxide synthase activity.
2006-01
Synthesis and antitumor activity of some novel quinazoline derivatives bearing the biologically active thione moiety.
2006
Tetrahydrobiopterin depletion and ubiquitylation of neuronal nitric oxide synthase.
2005-12-07
Inhibition of brain GTP cyclohydrolase I and tetrahydrobiopterin attenuates cerebral infarction via reducing inducible NO synthase and peroxynitrite in ischemic stroke.
2005-12
Immobilization stress causes increases in tetrahydrobiopterin, dopamine, and neuromelanin and oxidative damage in the nigrostriatal system.
2005-10
Crystal structure and luminescence of lanthanide monodentate complexes [Ln(C(4)N(4)H(6)O)(2)(H(2)O)(6)]Cl(3) and [Ln(C(4)N(4)H(6)O)(2)(H(2)O)(3)(NO(3))(3)] (Ln = Tb or Eu).
2005-06-13
Synthesis of classical, three-carbon-bridged 5-substituted furo[2,3-d]pyrimidine and 6-substituted pyrrolo[2,3-d]pyrimidine analogues as antifolates.
2004-12-30
Effect of tetrahydrobiopterin on nitric oxide synthase-containing cells in the rat hippocampus.
2004-10
The mechanism of potent GTP cyclohydrolase I inhibition by 2,4-diamino-6-hydroxypyrimidine: requirement of the GTP cyclohydrolase I feedback regulatory protein.
2004-09-24
A new and efficient synthesis of pyrrolo[2,3-d]pyrimidine anticancer agents: Alimta (LY231514, MTA), homo-Alimta, TNP-351, and some aryl 5-substituted pyrrolo[2,3-d]pyrimidines.
2003-12-26
Tetrahydrobiopterin, a critical factor in the production and role of nitric oxide in mast cells.
2003-12-12
Antiangiogenic and antitumor agents. Design, synthesis, and evaluation of novel 2-amino-4-(3-bromoanilino)-6-benzylsubstituted pyrrolo[2,3-d]pyrimidines as inhibitors of receptor tyrosine kinases.
2003-11-17
GTP cyclohydrolase 1 inhibition attenuates vasodilation and increases blood pressure in rats.
2003-11
Kainic acid lesion-induced nigral neuronal death.
2003-08
Exogenous biopterins requirement for iNOS function in vascular smooth muscle cells.
2003-08
Interactions of peroxynitrite, tetrahydrobiopterin, ascorbic acid, and thiols: implications for uncoupling endothelial nitric-oxide synthase.
2003-06-20
Tetrahydrobiopterin precursor sepiapterin provides protection against neurotoxicity of 1-methyl-4-phenylpyridinium in nigral slice cultures.
2003-04
Increased vulnerability to ischemia/reperfusion-induced ventricular tachyarrhythmias by pre-ischemic inhibition of nitric oxide synthase in isolated rat hearts.
2003-02-25
HMG-CoA reductase inhibitor increases GTP cyclohydrolase I mRNA and tetrahydrobiopterin in vascular endothelial cells.
2003-02-01
Wavelength-dependent induction of a mycosporine-like amino acid in a rice-field cyanobacterium, Nostoc commune: role of inhibitors and salt stress.
2003-02
Role of tetrahydrobiopterin on ischemia-reperfusion injury in isolated perfused rat hearts.
2003-02
Non-classical antifolates, 5-(N-phenylpyrrolidin-3-yl)-2,4,6-triaminopyrimidines and 2,4-Diamino-6(5H)-oxopyrimidines, synthesis and antitumor studies.
2003-01-02
Effect of 2,4-diamino-6-hydroxy-pyrimidine on postburn Staphylococcus aureus sepsis in rats.
2002-11
Tetrahydrobiopterin deficiency increases neuronal vulnerability to hypoxia.
2002-09
Possible involvement of tetrahydrobiopterin in the trophic effect of insulin-like growth factor-1 on rat pheochromocytoma-12 (PC12) cells.
2002-08-09
Lack of nitric oxide mediation of flow-dependent arteriolar dilation in type I diabetes is restored by sepiapterin.
2002-05-02
[The protective effects and its underlying mechanism of 2,4-diamino-6-hydroxy-pyrimidine on postburn Staphylococcus aureus sepsis in rats].
2002-04
A new one-pot three-component condensation reaction for the synthesis of 5-deaza-5,8-dihydropterins.
2001-12-07
Guanosine triphosphate cyclohydrolase I regulates nitric oxide synthesis in renal proximal tubules.
1995-02
Patents

Sample Use Guides

Male Wistar rats: animals were intraperitoneally injected with a dose of 1 g/kg 2,4-diamino-6-hydroxy-pyrimidine (DAHP) before Staphylococcus aureus challenge and then were further divided into 2- and 6-hr groups
Route of Administration: Intraperitoneal
In Vitro Use Guide
In interferon-gamma-activated murine peritoneal macrophages 2,4-diamino-6-hydroxy-pyrimidine suppresses the expression of iNOS mRNA and protein in a tetrahydrobiopterin (BH4)-independent manner and, thus, acts by a novel mechanism.
Substance Class Chemical
Created
by admin
on Mon Mar 31 19:11:55 GMT 2025
Edited
by admin
on Mon Mar 31 19:11:55 GMT 2025
Record UNII
EDH7CNS75I
Record Status FAILED
Record Version
  • Download
Name Type Language
2-Aminoisocytosine
Common Name English
2,4-DIAMINO-6-HYDROXYPYRIMIDINE
MI  
Preferred Name English
NSC-9302
Code English
NSC-680818
Code English
4(1H)-PYRIMIDINONE, 2,6-DIAMINO-
Systematic Name English
NSC-44914
Code English
2,6-DIAMINO-4(3H)-PYRIMIDINONE
Systematic Name English
4(3H)-PYRIMIDINONE, 2,6-DIAMINO-
Systematic Name English
2,4-DIAMINO-6-HYDROXYPYRIMIDINE [MI]
Common Name English
Code System Code Type Description
PUBCHEM
135408763
Created by admin on Mon Mar 31 19:11:55 GMT 2025 , Edited by admin on Mon Mar 31 19:11:55 GMT 2025
PRIMARY
CAS
100643-27-4
Created by admin on Mon Mar 31 19:11:55 GMT 2025 , Edited by admin on Mon Mar 31 19:11:55 GMT 2025
ALTERNATIVE
NSC
680818
Created by admin on Mon Mar 31 19:11:55 GMT 2025 , Edited by admin on Mon Mar 31 19:11:55 GMT 2025
PRIMARY
MERCK INDEX
m4253
Created by admin on Mon Mar 31 19:11:55 GMT 2025 , Edited by admin on Mon Mar 31 19:11:55 GMT 2025
PRIMARY Merck Index
EPA CompTox
DTXSID4049038
Created by admin on Mon Mar 31 19:11:55 GMT 2025 , Edited by admin on Mon Mar 31 19:11:55 GMT 2025
PRIMARY
ECHA (EC/EINECS)
200-254-4
Created by admin on Mon Mar 31 19:11:55 GMT 2025 , Edited by admin on Mon Mar 31 19:11:55 GMT 2025
PRIMARY
NSC
44914
Created by admin on Mon Mar 31 19:11:55 GMT 2025 , Edited by admin on Mon Mar 31 19:11:55 GMT 2025
PRIMARY
MESH
C017202
Created by admin on Mon Mar 31 19:11:55 GMT 2025 , Edited by admin on Mon Mar 31 19:11:55 GMT 2025
PRIMARY
CAS
56-06-4
Created by admin on Mon Mar 31 19:11:55 GMT 2025 , Edited by admin on Mon Mar 31 19:11:55 GMT 2025
PRIMARY
FDA UNII
EDH7CNS75I
Created by admin on Mon Mar 31 19:11:55 GMT 2025 , Edited by admin on Mon Mar 31 19:11:55 GMT 2025
PRIMARY
NSC
9302
Created by admin on Mon Mar 31 19:11:55 GMT 2025 , Edited by admin on Mon Mar 31 19:11:55 GMT 2025
PRIMARY